Friday 6 November 2026
Export PODD’s income statement to Excel — free account
Insulet Corporation
PODD Healthcare Medical Devices
Insulet Corporation’s revenue for fiscal 2025 (year ended December 2025) was $2.7 billion, up 30.7% from fiscal 2024.
- Revenue
- +19.2%
- EPS
- +64.1%
- Free cash flow
- −29.8%
- Total debt
- −5.19%
Quarter to September 2026, against a year earlier
145.49
10.63
−6.81%
Follow PODD
Alert me
Insulet Corporation (PODD) revenue by segment, product and region
Where the money comes from and where it goes
| U.S. | 1,920 | 70.89% |
|---|---|---|
| International | 754 | 27.85% |
| Drug Delivery | 34 | 1.26% |
| Gross margin | 71.63% | |
| Operating margin | 17.50% | |
| Pre-tax margin | 12.54% |
Revenue by product or service $m
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| U.S. | 1,920 70.89% | 1,509 72.86% | 1,251 73.71% | 885 67.79% | 652 59.29% | 527 58.26% | 420 56.95% | 324 57.38% | 272 58.56% | 230 62.61% | 190 71.85% | 176 76.06% |
| International | 754 27.85% | 523 25.27% | 410 24.16% | 363 27.81% | 360 32.75% | 308 34.06% | 253 34.29% | 172 30.51% | 120 25.87% | 72 19.59% | 40 15.29% | 50 21.63% |
| Drug Delivery | 34 1.26% | 39 1.88% | 36 2.12% | 58 4.41% | 87 7.95% | 70 7.68% | 65 8.76% | 68 12.11% | 72 15.57% | 65 17.80% | 34 12.87% | 5 2.31% |
| Total Omnipod products | 2,674 | 2,033 | 1,661 | 1,248 | 1,011 | 835 | 674 | 496 | 392 | — | — | — |
| Revenue | 2,708 | 2,072 | 1,697 | 1,305 | 1,099 | 904 | 738 | 564 | 464 | 367 | 264 | 231 |
Gross profit by product or service $m, and margin
Revenue by region $m
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| U.S. | 1,954 72.15% | 1,548 74.73% | 1,287 75.84% | 942 72.19% | 739 67.25% | 596 65.94% | 485 65.71% | 392 69.49% | 344 74.13% | 295 80.41% | 224 84.71% | 181 78.37% |
| International | 754 27.85% | 523 25.27% | 410 24.16% | 363 27.81% | 360 32.75% | 308 34.06% | 253 34.29% | 172 30.51% | 120 25.87% | 72 19.59% | 40 15.29% | 50 21.63% |
| Revenue | 2,708 | 2,072 | 1,697 | 1,305 | 1,099 | 904 | 738 | 564 | 464 | 367 | 264 | 231 |